Ken Frazier is joining
General Catalystas its chairman of health assurance initiatives, a role the venture capital firm created to ramp up its investments in healthcare and pharma.
Frazier just recently stepped down from his previous role as CEO of Merck, where he spent nearly a decade encouraging the pharma giant to prioritize research and pursue novel vaccines and therapeutics.
At General Catalyst, he’ll be laying out strategy for the firm’s healthcare initiatives, fostering partnerships between healthcare and pharma and targeting health equity opportunities. He’ll also be in control of its $600 million Health Assurance Fund which was unveiled back in April.
Komodo Health Names Bill Madigan as Chief Revenue Officer
cadillacnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cadillacnews.com Daily Mail and Mail on Sunday newspapers.
Letter from Gatemore Capital Management LLP to Sensyne Health PLC
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Medical Affairs Teams are Increasingly Turning to Patient-centric Analytics to Improve Clinical Outcomes
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.